Article Details
Retrieved on: 2022-12-23 10:19:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BERLIN (Reuters) - BioNTech has initiated a first-in-human Phase 1 clinical trial of its BNT165b1 malaria vaccine candidate using mRNA technology, ...
Article found on: wtvbam.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here